chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Web report received from hospital. per notes from hospital web-report: this patient presented from his memory care facility with a chief complaint of altered mental status. Patient resided at a memory care facility. Facility stated patient is usually A&Ox2-3.  Yesterday he was not eating or drinking and was less interactive. Patient tested positive for COVID at the memory care unit. Staff noticed patient was more somnolent, more altered, weak, and had reportedly a fever. The patient reported per note that he felt "fine" but was extremely somnolent and only intermittently responded to the examiner. He reported he is "always" short of breath. Endorses a cough. ER exam was unable to obtain further information from patient at this time. Per note the Information on the hospital H&P was obtained from discussion with the patient, the patient's son/HCPOA, ED provider, and chart review. stating the patient was a difficult historian secondary to baseline dementia and current acute toxic metabolic encephalopathy. Patient was admitted 9/04/2022. 2nd web-report received, noted -terminal diagnosis of covid-19. Family/HPOA opted for comfort measures and patient expired 9/12/22 at 10:46pm.  Moderna 11/19/2021    LOT: 012H21B,  Moderna 1/14/2022       LOT:033H21A,  Moderna 6/22/2022       LOT: 054A22A HEALTH DEPARTMENT DOESNOT HAVE ANY FURHTER INFORMATON ON THIS PATIENT
Injection site reaction approximately 2"-3" (raised area, redness, itching) occurred about 24 hrs post injection. At about 96 hours post-injection area was red and approximately half-dollar sized.
woke up in the middle of the night with fever and chills, had headaches and body aches for 3 days after
Information has been received from a 24 year old female with family history of blood clots, her grandmother and mother were factor 5, and no drug reactions/allergies who in April 2009, was vaccinated with the first dose of GARDASIL (Lot # not reported). In June 2009, the patient was vaccinated with the second dose of GARDASIL (Lot # not reported). Concomitant therapy included hormonal contraceptives (unspecified). On 06-JUL-2009, the patient was diagnosed with a blood clot and was admitted to the hospital for less than 1 day. On an unspecified date, the patient had a factor 5 test and an ultrasound performed (results not provided). In the end of July 2009, the patient recovered from blood clot. Additional information has been requested.  9/18/09 Hospital records received DOS 7/8/09 to 7/9/09. Assessment: Acute deep venous thrombosis in right leg.  Soft ball injury to leg, multiple abrasions 1 week prior. Presents with exquisite right calf pain. Superficial phlebitis of right lesser sapheous, occluded calf vein, thrombosis of right gastronemius vein, occluded deep vein thrombosis of right superficial femoral and popliteal veins.  ICD-9 Codes: 782.3 Edema, 451.0 Superfic Phlebitis - Leg, 916.0 Abrasion Hip & Leg, 346.90 Migrne Unsp wo Ntrc Mgrn, V18.3 HX-Blood Disord Nec.
Headache, muscle sore, fever (yesterday) chest tightness, SOB 48 year old female.
Presented with pneumonia due to COVID-19 virus, acute respiratory failure with hypoxia.  Tx w/ IV abx, remdesivir, steroids & O2. Weaned to RA for dc home.
Stomach cramps, very soft stool and diarrhea. 4 instances in 30 hours. Worst instance around 20 hours after vaccination. Symptoms seems to be lessening around 30 hours after vaccination.
2 Years old  Male with no contributing comorbidities brought in by mother presenting with upper respiratory infection symptoms x 2 days.  Patient received the influenza vaccination yesterday and since then he has been showing symptoms of fever and abdominal pain.  Symptoms viewed as moderate in nature with pain described as better with nothing, worse with nothing.  Positive history of other contacts with same symptoms. No travel overseas.  04/14/23 14:06:12 Dr at bedside evaluating patient. Based on exam, Dr. states that the swelling is likely secondary reaction to the vaccination given yesterday. At this time to help with the swelling, we can give a dose of Dexamethasone. 04/14/23 18:38:14 Patient is doing well, eating and drinking. Patient is stable for discharge. Patient will follow up with primary care doctor in 1-2 days and will provide strict return precautions.  This patient's history and exam are consistent with an enlarge adenoids likely secondary reaction to vaccination recently received. Based on the history, exam, and any testing done, I don't suspect an emergency cause patient's symptoms, such as, but not limited to, pneumonia requiring hospital admission, airway compromise, sepsis, or aspirated foreign body.     The patient/family understood and agreed with the follow-up plan, including return indications and follow-up with primary physician within 1 to 2 days for recheck.
Information has been received from a physician concerning a 2-month-old female who was vaccinated by mouth with a 2.0 ml dose of rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human-bovine) (lot number not provided).  Concomitant vaccinations administered on that same day included a dose of "another vaccine" (not further specified).  The physician reported that the patient subsequently vomited twice.  Unspecified medical attention was sought.  Subsequently, the patient recovered.  Additional information has been requested.
About 10 PM the child began to cry uncontrollably, appeared very uncomfortable, and his abdomen was hard to the touch.  Ultrasound consistent with intussusception.
Psoriasis patches everywhere on chest belly; This spontaneous case was reported by a consumer and describes the occurrence of PSORIASIS (Psoriasis patches everywhere on chest belly) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB for Plaque psoriasis and Psoriatic arthritis.    Concurrent medical conditions included Psoriatic arthritis.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started RISANKIZUMAB (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced PSORIASIS (Psoriasis patches everywhere on chest belly). At the time of the report, PSORIASIS (Psoriasis patches everywhere on chest belly) had not resolved.            No concomitant medications were provided by the reporter.  No treatment medications were provided by the reporter.  The reporter's causality for the event Psoriasis patches everywhere on chest belly / not improving skin on Skyrizi unknown onset with SKYRIZI (RISANKIZUMAB) was no reasonable possibility.
Patient received Moderna #1 vaccine to left deltoid; the next day he had a grapefruit size swelling to his left axilla.  He went to his PCP who obtained an ultrasound which showed lymph node swelling.
Received H1N1 in Rt arm & seasonal vaccine in the Lt arm 11/2/09 @ 4 pm. Woke up 11/4/09 morning & had severe pain posterior lower neck radiating to Rt. arm & up the back of her head. Went to her Dr 11/5 and was off work until 11/16. Had severe pain that whole time. Could not use right hand because it caused pain. Began physical therapy 11/11 & is still continuing 11/24. Neck has remained stiff-cannot move without pain.
Symptoms included Sciatica on legs; This spontaneous case was reported by a consumer and describes the occurrence of SCIATICA (Symptoms included Sciatica on legs) in a 71-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SCIATICA (Symptoms included Sciatica on legs). At the time of the report, SCIATICA (Symptoms included Sciatica on legs) outcome was unknown. Not Provided          Concomitant medication was not reported.  Treatment included acupuncture.  Action taken with mRNA-1273 in response to the event was Not Applicable
Extreme fatigue and nausea and vomiting; Extreme fatigue and nausea and vomiting; Extreme fatigue and nausea and vomiting; This is a spontaneous report from a contactable nurse. A 40-years-old female patient started to the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), Batch/lot number: Unknown, intramuscularly on 23Dec2020 11:30 (at the age of 40-years-old) as a single dose in the right arm  for COVID-19 immunization.  The patient did not have allergies to medications, food, or other products. Concomitant medication included metformin, zolpidem tartrate (AMBIEN), venlafaxine hydrochloride (EFFEXOR XR). The most recent COVID-19 vaccine was administered in the hospital. The patient was not pregnant at the time of vaccination.  Prior to vaccination, the patient was not diagnosed with COVID-19. On 23Dec2020 14:30, the patient experienced extreme fatigue and nausea and vomiting.  The extreme fatigue and nausea and vomiting did not result in death, was not life-threatening, did not cause/prolonged hospitalization, was not disabling/incapacitating and did not cause congenital anomaly/birth defect. No treatment was received for the event. Outcome of the event extreme fatigue and nausea and vomiting was recovering. Since the vaccination, the patient has not been tested for COVID-19. Information on lot/batch number has been requested.
45 minutes after the vaccine I started with all over body itching, had not eaten, drank or taken anything between the shot and time of the itching.  I did about 20 minutes after the shot have a headache, severe arm pain, and then later that evening I had body aches, and the lymph node under my arm swelled up. I am still having the arm pain, swollen lymph node and itching and its 5 days later.  I have been taking my already prescribed allergy medications as well as Benadryl and Claritin as advised by my doctor.
Pt recvd HIB vax & the next day devel t104;  MD was not sure if vax was related to fever; No further details were provided;
Anaphylactic shock. Patient said approximately 4 hours post vaccination, her face/tongue/neck swelled. Patient was home alone. She took benadryl and used her rescue inhaler and eventually she was okay.
I didn't think I had an adverse reaction until just now I read that herpes is one in several people. The day I had the vaccine I was sleepy and had a headache but nothing major. I did notice the next morning a rash of some sort on my right arm. Lower arm. Red raised bumps. Nothing that important I didn't think. They are still there six days later. There is sometimes like a lightning burst of pain where they are. Just come and go. I'm not that concerned about it and hope I don't have to be. But like I said after reading the headline thought I should let you know.
pt reports having "tingling that started in left hand, progressed up to left arm and face, then started right hand and arm to face, and felt difficulty with speaking in addition to headache. it felt like i was coming off novacaine and i was able to speak but i felt like i was a robot speaking and had to think about it. The tingling and difficulty speaking lasted about 30min, i took a hot bath cause arm was so sore and head hurt, and went to bed. Did not sleep well due to headach and had to urinate all night long. i was exhausted next day. Today I still feel slight decreased feeling around mouth, otherwise feel back to normal." "I also had shivers with elevated HR by 20 bpm abve rhr all night. "
Pt's. mom states pt. arm is swelling and c/o pain injection site times 2 days.
I have vaginal bleeding and then it stopped on its own after two weeks and the bleed healed up. Dr visit - no treatment - peri gestational hematoma.   My due date is 9/18/2021; my second history - I have one living child.
Dizziness; Vertigo; Sweating 2-3 min after injectionLasted 1-2 min; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 14:45 (at the age of 27-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient did not receive any medications within two weeks of vaccination. On 09Apr2021 at 14:45, 2 to 3 minutes after the injection, the patient experienced dizziness, vertigo and sweating which lasted for 1 to 2 minutes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizziness, vertigo and sweating was recovered on 09Apr2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Menstrual like cramps,  started an unexpected period just 2 weeks after the usual one, and has a swollen lymph node(s) under her arm.  The swollen lymph node(s) were still not gone when the 2nd shot was given.  The doctor said to go ahead and get the 2nd shot.
SPLOTCHY RASH ON FACE AND LITTLE RED BUMPS WERE ITCHY BEHIND EARS.
Difficulty swallowing and lip swelling, given Benadryl, Zyrtec and Prednisone at 8:05. Swelling went down by 10 am. Has some tingling in hands and feet through out that day, but stopped after 24 hrs. Had some pain in left armpit on Sunday and Monday.  No more symptoms today.
At 12:13 on 11/10/21, the client came to our facility requesting a COVID19 booster shot.  Lead RN was requested to speak with the client to determine his eligibility for the vaccine.  The client stated he was homeless and currently residing at a homeless shelter.  He did not have any identification or other documentation to verify his identity.  His counselor, who also came to receive a Covid19 vaccine, had valid identification and was able to verify the client?s identity.   This form of identification for the client was authorized by the clinical leads.  The client claimed he received the 1st dose of a Covid19 vaccine while in a Detention Facility around May 2020 and the 2nd dose of a Covid19 vaccine in August 2020.  The client could not recall the name of the vaccine, but stated he was told that he was receiving a Covid19 vaccine.  Lead RN explained to the client the Covid19 vaccines were not available to the public at that time and asked if he believed that he might have received another vaccine.  The client said he wasn?t sure, but that is what he thought he had received.  The client then stated that while walking around town in September 2021, he was approached by 2 nurses with a police officer who asked if he would like to be vaccinated.  He agreed, but does not know what type of vaccine he received.  An Immunization Registry Representative reviewed the client?s immunization information in the IR system and found no record of the client ever receiving a Covid19 vaccine. After speaking with the client, Lead RN determined the client was of sound mind and capable of advocating for himself.  Lead RN conducted a medical consult with the clinical leads to determine if the client was eligible to receive a Covid19 vaccine.  The client was unable to wait for the consult to be completed and asked if we could call his counselor and leave a message with her once we had an answer.  At 17:20, Lead RN was notified by the clinical leads the client was approved by a County doctor to receive the Covid19 Pfizer 2-dose vaccine series.  Lead RN called the client?s counselor t 17:26 and left a message for the client to return to the facility at his earliest convenience.  On 11/11/21, the client arrived at the facility to receive the Covid19 Pfizer vaccine.  The client received dose 1 of the Covid19 Pfizer vaccine (Lot#FF8839) at 12:07 and was observed for 15 minutes by an LVN in the observation room.  LVN observed the client leave the facility at 12:30 walking with a steady gait. VAERS Submission # & VERP submission #.
pt recvd vax 30JUL93 & 31JUL started w/swelling lt side of face progressing to marked b/l involvement t100.4;
Hospitalized 11/6/2021; COVID-19 positive 11/6/2021; fully vaccinated  BRIEF OVERVIEW:   Admission Date: 11/6/2021 Discharge Date: 11/8/2021  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute hyponatremia  Hyponatremia  Diarrhea, unspecified type  COVID-19   HOSPITAL COURSE: This is a 68-year-old gentleman who initially developed symptoms of COVID respiratory is symptoms about 10 days prior to admission.  These subsequently resolved, but then he developed severe watery diarrhea with abdominal cramping.  On the day of admission he felt dizzy and lightheaded and weak.  He was found to have hyponatremia with a sodium of 117. He did not have any hypoxemia or any ongoing respiratory symptoms related to COVID.  He was initially treated with normal saline but had a rapid increase in his sodium level up to 125 and 8 hours, which led to reversal treatment of hyponatremia with desmopressin and a D5 W fluid bolus.  Sodium then slowly dropped down to 119. He was restarted on saline and his sodium increased back to 125 by the evening prior to discharge and 02/01/2032 by the morning of discharge.  The patient reported he had had prior problems with mild hyponatremia down to 131 related to hydrochlorothiazide in his blood pressure pill  He will be discharged with discontinuation of hydrochlorothiazide, and replacement of his combination lisinopril hydrochlorothiazide pill with lisinopril 10 mg daily.  He is prone to lower extremity edema and was prescribed Lasix 20 mg daily p.r.n. edema replace the hydrochlorothiazide.
Approximately 12 days post vaccination, vaccination spot became swollen, red, and firm, slightly bothersome and itchy
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Shoulders down to her wrist are so sore), LIGAMENT PAIN (Almost affected her ligaments) and LIMB DISCOMFORT (Spread into her left arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. G12M20A and 048A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included DENOSUMAB (PROLIA).   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (Shoulders down to her wrist are so sore), LIGAMENT PAIN (Almost affected her ligaments) and LIMB DISCOMFORT (Spread into her left arm). At the time of the report, PAIN IN EXTREMITY (Shoulders down to her wrist are so sore), LIGAMENT PAIN (Almost affected her ligaments) and LIMB DISCOMFORT (Spread into her left arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was unknown
Patient should have received a TDAP. A KINRIX was given instead. To old for KINRIX.
Generalized tonic/clonic seizure at home at 6 AM, seen at ER. Recovered without incident. Seen in office at about 10 AM. 2nd tonic/clonic seizure lasting 90-120 seconds. Recovered without incident. Sent to ER.
Postpartum; Breastfeeding; Maternal Exposure before pregnancy; Had a c-section at 34 weeks; This spontaneous retrospective pregnancy case was reported by a nurse and describes the occurrence of POSTPARTUM DISORDER (Postpartum), PREMATURE DELIVERY (Had a c-section at 34 weeks), BREAST FEEDING (Breastfeeding) and MATERNAL EXPOSURE BEFORE PREGNANCY (Maternal Exposure before pregnancy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 18-Dec-2021, the patient experienced PREMATURE DELIVERY (Had a c-section at 34 weeks). On an unknown date, the patient experienced POSTPARTUM DISORDER (Postpartum), BREAST FEEDING (Breastfeeding) and MATERNAL EXPOSURE BEFORE PREGNANCY (Maternal Exposure before pregnancy). The cesarean delivery occurred on 18-Dec-2021, which was reported as Premature. For neonate 1, The outcome was reported as Delivered NOS. Patient was pumping and breastfeeding. At the time of the report, POSTPARTUM DISORDER (Postpartum) and PREMATURE DELIVERY (Had a c-section at 34 weeks) outcome was unknown and BREAST FEEDING (Breastfeeding) and MATERNAL EXPOSURE BEFORE PREGNANCY (Maternal Exposure before pregnancy) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications list was not provided. Treatment information was not provided.   Patient needed to get her booster, and second dose was back in January. Patient was postpartum and wanted to make sure there were no contraindications to get the booster.
Patient reported to me over a year from the date of administration that about a week after the vaccine he started to develop fluorescent green snot that lasted about 9 months as well as a loss of smell.  Patient told me that he reported it to the PCP, but PCP wasn't concerned.  I advised the patient that it was probably a case of Covid-19 that occurred about the same and not related to the vaccine, but did tell patient I would report it as a possible vaccine related event.
After the first dose the next day strong pain in my left arm from the elbow to the wrist, Ceased the next day. After the second dose strong pain in the left side of my neck and back, mild pain in the injection site, malaise and muscular ache, all these symptoms improve the next day.
Information has been received from a healthcare worker (immunization official) concerning an unknown number of patients who on unspecified dates, might have been vaccinated with PNEUMOVAX 23 (lot number, dose and route not reported) that was improperly stored. The healthcare worker called for a stability check for the vaccines that were exposed to 16.2 C for 9 hours. At the time of the report no adverse events were reported. This is one of several reports received from the same source. All telephone attempts to obtain follow up information have been unsuccessful. Additional information has been requested.